Art Technology Acquisition Corp. ARTC
Set alert
10.02 USD 0.00 0.00%
At close · Oct 30
10.00 -0.02 -0.15%
After hours · Oct 30, 4:00 PM ET
10.02 Day range 10.02
9.79 52-week range 10.04
- YTD
- +1.88%
- 1 year
- +1.88%
- Open
- 10.02
- Prev close
- 10.02
- Mkt cap
- 261.64M
- Vol
- 243
- Avg vol
- 35.78K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.02
- High
- 10.02
2Y chart
Signals (23)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 1 day ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 6, 2026 | 5 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
Financials — quick view
ARTC Revenue — quarterly 0
ARTC Net income — quarterly 1.92M
ARTC EPS — quarterly 0.06
News
- ArthroCare Q1 Earnings Miss Ests; Revs In Line - Analyst Blog
- ArthroCare Corporation Reports Q1 EPS of $0.32 vs $0.36 Est; Revenue of $96.10M vs $95.80M Est
- MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
- MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
- Varian Medical Systems Settles Patent Dispute - Analyst Blog
- Thoratec Slapped with Class I Recall for HeartMate Controller - Analyst Blog
- Balanced View on Cyberonics - Analyst Blog
- ArthroCare Corporation Reports Q4 EPS of $0.30 vs $0.39 Est; Revenue of $101.70M vs $100.65M Est
- Benzinga's M&A Chatter for Monday February 3, 2014
- Market Wrap For February 3: Bears In Complete and Absolute Control
Your note
Sign in to keep a note on ARTC — it syncs with the Stock Master app.